Quidel Quickvue Respiratory Syncytial Virus (Rsv)

The Quidel QuickVue RSV test is designed for rapid, efficient point-of-care diagnosis, facilitating timely clinical decisions. Here are the key efficiency metrics: * Time to Results: Provides qualitative detection results for the Respiratory Syncytial Virus (RSV) antigen in just 15 minutes. * Efficiency: The test is highly streamlined, requiring less than 30 seconds of hands-on time and only 3 simple steps using a single reagent. * Regulatory Status: Both available configurations are CLIA Waived, simplifying regulatory compliance for many clinical facilities.

The Quidel QuickVue RSV test provides versatile detection by accepting multiple types of respiratory specimens for use in the rapid qualitative detection of the RSV antigen. The compatible specimen types are:

• Nasopharyngeal swab
• Nasopharyngeal aspirate
• Nasal/Nasopharyngeal wash specimens

The complete kit is designed for immediate use and includes sterile nasopharyngeal swabs and external controls.

The Quidel QuickVue RSV test provides exceptionally rapid results, designed to facilitate timely clinical decisions at the point of care. The key timing specifications are:

• Time to Results: Results are delivered in just 15 minutes.
• Hands-On Time: The entire procedure requires minimal operator time, with less than 30 seconds of hands-on time.

This speed is achieved through a simple, three-step diagnostic process utilizing only one reagent. The system is also designated as CLIA Waived and operates using nasopharyngeal swab, aspirate, or wash specimens.

Yes, the Quidel QuickVue RSV test is designed as a comprehensive, rapid diagnostic solution, including all necessary components for point-of-care testing.

Key Inclusions and Features:

• Complete Components: The kit includes the essential external controls and sterile nasopharyngeal swabs needed for accurate testing and quality control.
• Rapid & Simple Process: Results are available in just 15 minutes. The test requires only 3 simple steps, utilizing a single reagent, and demanding less than 30 seconds of hands-on time.
• Regulatory Status: Both available configurations are designated as CLIA Waived, simplifying regulatory compliance.
• Convenient Storage: The entire kit is stable and designed for storage at room temperature, minimizing special storage requirements.

Yes, the Quidel QuickVue RSV test kit is designed to maintain stability when stored at room temperature. This simplifies logistics and storage, making it highly convenient for various clinical and point-of-care testing environments.

Yes, the Quidel QuickVue RSV test is designed for maximum speed and simplicity, making it ideal for efficient point-of-care diagnosis. It requires minimal time and steps to operate.

Key features that highlight its ease of use:

• Rapid Results: Delivers qualitative detection results for the RSV antigen in just 15 minutes.
• Minimal Hands-On Time: The testing process is highly streamlined, requiring only 3 simple steps, a single reagent, and less than 30 seconds of direct user interaction.
• CLIA Waived: All configurations are designated as CLIA Waived, simplifying regulatory compliance for many facilities.
• Convenient Storage: The entire kit is designed to be stored at standard room temperature.
• Comprehensive Kit: Each package includes necessary components, such as external controls and sterile nasopharyngeal swabs, for immediate testing.

Yes, the Quidel QuickVue RSV test is highly efficient, requiring only one reagent for the entire procedure. This streamlined design minimizes complexity and delivers rapid results, which is a key benefit for point-of-care settings.

Key efficiency details:

• The test involves only 3 simple steps.
• The hands-on time is exceptionally brief, lasting less than 30 seconds.
• Results are ready in just 15 minutes.
• The CLIA Waived status also simplifies usage and regulatory compliance.

The Quidel QuickVue RSV test is designed for the rapid, qualitative detection of the Respiratory Syncytial Virus (RSV) antigen, specifically targeting the viral fusion protein. This allows for quick and accurate identification of RSV infections.

Yes, both available configurations of the Quidel QuickVue RSV test are designated as CLIA Waived.

This designation simplifies regulatory compliance, making the test an ideal solution for rapid screening in decentralized or point-of-care settings.

Key features that highlight the test’s efficiency and simplicity include:

• Rapid Results: Qualitative detection of the RSV antigen is provided in just 15 minutes.
• Ease of Use: The procedure involves only 3 simple steps and requires a single reagent.
• Minimal Hands-On Time: Less than 30 seconds of direct user interaction is required.
• Convenient Storage: The kit is designed to be stored at room temperature.
• All-Inclusive Kit: External controls and sterile nasopharyngeal swabs are included in the package.

The Quidel QuickVue RSV test is designed for the rapid, qualitative detection of the RSV antigen (viral fusion protein) and is compatible with the following respiratory specimen types:

• Nasopharyngeal swab (Sterile swabs are conveniently included in the kit)
• Nasopharyngeal aspirate
• Nasal/nasopharyngeal wash specimens